• 1
    Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;8:5129.
  • 2
    Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291:8814.
  • 3
    Stecher B, Robbiani R, Walker AW et al. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 2007;5:217789.
  • 4
    Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol 2005;174:445360.
  • 5
    Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000;406:782787.
  • 6
    Kimura K, McCartney AL, McConnell MA, Tannock GW. Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl Environ Microbiol 1997;63:33948.
  • 7
    Du Clos TW, Mold C. The role of C-reactive protein in the resolution of bacterial infection. Curr Opin Infect Dis 2001;14:28993.
  • 8
    Rossbacher J, Wagner L, Pasternack MS. Inhibitory effect of haptoglobin on granulocyte chemotaxis, phagocytosis and bactericidal activity. Scand J Immunol 1999;50:399404.
  • 9
    Schumann RR, Leong SR, Flaggs GW. Structure and function of lipopolysaccharide binding protein. Science 1990;249:142931.
  • 10
    Dunzendorfer S, Lee HK, Soldau K, Tobias PS. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J 2004;18:111729.
  • 11
    Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004;109:II210.
  • 12
    Kossaify A, Garcia A, Succar S et al. Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management. Biomark Insights 2013;8:11526.
  • 13
    Krueger M, Schroedl W, Isik W, Lange W, Hageman L. Effects of lactulose on the intestinal microflora of periparturient sows and their piglets. Eur J Nutr 2002;41:I2631.
  • 14
    Kleessen B, Elsayed NA, Loehren U, Schroedl W, Krueger M. Jerusalem artichokes stimulate growth of broiler chickens and protect them against endotoxins and potential fecal pathogens. J Food Prot 2003;66:2171275.
  • 15
    Schroedl W, Jaekel L, Krueger M. C-reactive protein and antibacterial activity in blood plasma of colostrum-fed calves and the effect of lactulose. J Dairy Sci 2003;86:331320.
  • 16
    Wilson KH, Blitchington RB. Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 1996;7:22738.
  • 17
    Welling GW, Elfferich P, Raangs GC, Wildeboer-Veloo AC, Jansen GJ, Degener JE. 16S rRNA-targeted oligonucleotide probes for monitoring of intestinal tract bacteria. Scand J Gastroenterol 1997;32:179.
  • 18
    Kleessen B, Noack J, Blaut M. Distribution of viable and non-viable bacteria in the gastrointestinal tract of gnotobiotic and conventional rats. Microb Ecol Health Dis 1999;11:21825.
  • 19
    Roller C, Wagner M, Amann W, Ludwig W, Schleifer KH. In situ probing of gram-positive bacteria with high DNA G+C content using 23S rRNA-targeted oligonucleotides. Microbiology 1994;140:284958.
  • 20
    Kleessen B, Schroedl W, Stueck M, Richter A, Rieck O, Krueger M. Microbial and immunological responses relative to high-altitude exposure in mountaineers. Med Sci Sports Exerc 2005;37:13138.
  • 21
    Amann RI, Ludwig W, Schleifer KH. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbial Rev 1995;59:14369.
  • 22
    Stahl DA, Amann R. Development and application of nucleic acid probes in bacterial systematics. In: Stackebrandt E, Goodfellow M, eds. Sequencing and Hybridization Techniques in Bacterial Systematics. England: John Wiley & Sons Chichester, 1991:20548.
  • 23
    Franks AH, Harmsen HJM, Raangs GC, Jansen GJ, Schut F, Welling GW. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998;64:333645.
  • 24
    Langendijk PS, Schut F, Jansen GJ et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in faecal samples. Appl Environ Microbiol 1995;61:30693075.
  • 25
    Harmsen HJM, Elfferich P, Shut F, Welling GW. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 1999;11:312.
  • 26
    Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer KH. Phylogenetic oligodeoxynucleotide probes for the major subclasses of proteobacteria: problems and solutions. System Appl Microbiol 1992;15:593600.
  • 27
    Poulsen LK, Licht TR, Rang C, Krogfelt KA, Molin S. Physiological state of E. coli BJ4 growing in the large intestines of streptomycin-treated mice. J Bacteriol 1995;177:58405.
  • 28
    Wilson MB, Nakane PK. Recent developments in the periodate method of conjugating horseradish peroxidase (HRPO) to antibodies. In: Knapp W, Holubar K, Wick G, eds. Immunofluorescence and Related Staining Techniques. Amsterdam: North-Holland Biomedical Press, Elsevier, 1978:21524.
  • 29
    Horadagoda NU, Knox KM, Gibas HA. Acute phase proteins in cattle: discrimination between acute and chronic inflammation. Vet Rec 1999;144:43741.
  • 30
    Schroedl W, Fuerll B, Reinhold P, Krueger M, Schuett C. A novel acute phase marker in cattle: lipopolysaccharide binding protein (LBP). J Endotoxin Res 2001;7:4952.
  • 31
    Harris G, Kuolee R, Chen W. Role of Toll-like receptors in health and diseases of gastrointestinal tract. World J Gastroenterol 2006;12:214960.
  • 32
    Serrano M, Moreno-Navarrete JM, Puig J et al. Serum lipopolysaccharide-binding protein as a marker of atherosclerosis. Atherosclerosis 2013;230:2237.
  • 33
    Vermeire S, Van Assche D, Rutgeerts P. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2005;2:5806.
  • 34
    Furrie E, Macfarlane S, Thomson G, Macfarlane GT. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005;115:56574.
  • 35
    Kelly D, Campbell JI, King TP et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004;5:10412.
  • 36
    Morimatsu M, Watanabe A, Yoshimatsu K. Elevation of bovine serum C-reactive protein and serum amyloid P component levels by lactation. J Dairy Res 1991;58:25761.
  • 37
    Kleessen B, Hartmann L, Blaut M. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Brit J Nutr 2001;86:291300.
  • 38
    Swidsinski A, Loening-Baucke V, Bengmark S, Scholze J, Doerffel Y. Bacterial biofilm suppression with antibiotics for ulcerative and indeterminate colitis: consequences of aggressive treatment. Arch Med Res 2008;39:198204.